A clearer picture of a variable condition

Senior-Loken syndrome links retinal degeneration with kidney disease, but the timing and appearance of these features can differ greatly from person to person. That variability can make diagnosis challenging—especially when vision problems emerge years before kidney disease becomes apparent.

A new multicenter Japanese study in the American Journal of Ophthalmology examines 12 people with disease-causing changes in both copies of NPHP1, a gene associated with Senior-Loken syndrome. By combining long-term clinical records, retinal imaging, electrical testing of retinal function, and genetic analysis, the researchers provide an important view of how the eye disease can begin, change, and vary even within families.

For patients and families, the central message is clear: early-onset retinal degeneration can be an important clue to NPHP1-associated Senior-Loken syndrome, even when kidney disease has not yet been recognized.

The study followed patients across decades

The study included 10 people who came to eye clinics because of symptomatic retinal dystrophy, plus two affected siblings identified through family screening. Participants were recruited from six ophthalmic centers in Japan. Their follow-up ranged from no longitudinal follow-up to 44 years, with an average follow-up of 14.6 years.

The researchers used several complementary tests to characterize retinal disease:

  • Fundus photography, which documents the appearance of the back of the eye
  • Fundus autofluorescence (FAF), an imaging method that can reveal patterns of stress or degeneration in the retinal pigment epithelium
  • Optical coherence tomography (OCT), which provides cross-sectional images of retinal layers
  • Electroretinography (ERG), which measures the retina’s electrical responses to light

Genetic testing was conducted with whole-exome and/or whole-genome sequencing.

Retinal disease took several different forms

The 12 participants showed strikingly diverse retinal phenotypes. Four had cone or cone-rod dystrophy, in which cone photoreceptors—and sometimes rods—are affected. Four had retinitis pigmentosa. Two had sector retinitis pigmentosa, where degeneration is concentrated in particular retinal regions rather than being distributed more widely. One participant had pigmented paravenous retinochoroidal atrophy, a pattern of pigmentary and tissue changes along retinal veins. One participant had a clinically normal retina.

This range matters because it shows that NPHP1-associated disease cannot be identified by a single retinal appearance. The findings also extend the recognized spectrum of NPHP1-related retinal disease: the authors conclude that pigmented paravenous retinochoroidal atrophy can be associated with NPHP1 variants.

Variation was seen both between families and within families. In practical terms, relatives with the same genetic condition may not necessarily have identical eye findings or clinical courses.

A potential imaging clue: the descending tract

FAF imaging revealed a “descending tract” in five patients. This describes a characteristic pattern visible on FAF images. The authors propose that this feature may be a characteristic sign of retinal degeneration in Senior-Loken syndrome.

Although it was not present in every participant, this finding could become useful in the clinical evaluation of patients with early retinal degeneration. It also illustrates the value of FAF: retinal degeneration may produce informative patterns that are not fully captured by a standard eye examination alone.

Eye disease often came before kidney disease

One of the study’s most clinically meaningful observations concerns timing. In nine patients, retinopathy appeared before nephropathy. All nine had initially been diagnosed with Leber congenital amaurosis or early-onset retinal dystrophy.

This sequence can complicate the diagnostic journey. A child or young person may first be evaluated for severe, early retinal disease, while the kidney component of Senior-Loken syndrome is not yet evident. The study therefore reinforces the importance of considering NPHP1-associated Senior-Loken syndrome in people with Leber congenital amaurosis or early-onset retinal dystrophy, particularly when genetic testing identifies relevant variants.

Genetics: whole-gene deletion was common

Eleven of the 12 participants had a homozygous deletion of the entire NPHP1 gene. The remaining participant had compound heterozygous variants involving NPHP1 and EYS. These results highlight the central role of NPHP1 testing in this form of Senior-Loken syndrome and show why comprehensive genetic testing can help connect retinal findings with a broader syndromic diagnosis.

A molecular diagnosis can also identify affected relatives through family screening, as occurred in this study. Importantly, the presence of an NPHP1-related condition does not predict a single, uniform retinal phenotype.

Implications for care and future treatment research

This was not a treatment trial, but its detailed natural-history findings are valuable for future therapeutic research. Developing and assessing treatments requires a strong understanding of how disease begins and progresses, which retinal features are most informative, and how variable the condition can be.

For current clinical care, the study supports an approach that connects ophthalmic and kidney assessment over time. When early retinal degeneration is present, genetic results and longitudinal monitoring may help identify Senior-Loken syndrome before nephropathy is clinically recognized. Retinal imaging, especially FAF, may also provide useful markers for documenting disease patterns and change.

Looking ahead

The study shows that NPHP1-associated Senior-Loken syndrome is not defined by one retinal diagnosis or one predictable timeline. Instead, it is a genetically grounded condition with a broad spectrum of eye findings, in which retinal disease frequently precedes kidney disease.

Larger studies will be important to determine how consistently the descending tract appears, how retinal patterns relate to long-term clinical course, and whether particular genetic findings are associated with distinct presentations. For families facing early-onset retinal degeneration, research such as this helps sharpen the path from an eye-based diagnosis toward a more complete understanding of the underlying condition.